Skip to main content

Search

For society - planet

Our responsibility to the planet

Our responsibility to the planet

Our responsibility to the planet

As part of the world’s largest healthcare company, we recognise our responsibility – which stretches beyond industry regulations – to sustain natural resources and care for the planet. To do this, we push to continuously reduce our environmental impact and are committed to renewable and clean energy.

A healthy planet and a healthy community go hand in hand, and sustainability is about managing our personal, business and societal impacts to ensure better outcomes for patients and society.

Our commitment to protecting the environment and natural resources is enshrined in Our Credo, the set of values that guide decision-making across our company.

Read Our credo

 

Our Health for Humanity 2025 goals

 

Our citizenship and sustainability approach is linked to our vision of a world where a healthy mind, body and environment are within reach for everyone, everywhere.

Our UN SDG 2020 Commitment complements our Health for Humanity 2025 Goals, which focus our citizenship and sustainability efforts where we believe Johnson & Johnson can achieve the greatest impact.

Health for Humanity Report 2021

In 2021, we made notable advances in our Environmental Social and Governance performance and our Health for Humanity 2025 Goals.

Already, we have exceeded one Health for Humanity 2025 target and we’re on track to deliver against the remaining 20 goals.

Our milestones include the following.

To drive global health equity:

  • We provided our COVID-19 vaccine globally at a not-for-profit price and shipped 180 million doses of our single-shot COVID-19 vaccine to the African Union, COVAX and South Africa through advanced purchase agreements and country donations

  • We provided 731,000 nurses, midwives and community health workers with skills, tools and growth opportunities;

  • As part of Our Race for Health Equity, we invested in culturally competent community care models to close racial health gaps, reaching 159,000 healthcare professionals and researchers in the U.S.

  • We strengthened local economies by spending $4.5 billion with small and diverse suppliers, achieving a milestone in our accountable business practices.

To further empower employees:

We refreshed our Enterprise diversity, equity and inclusion strategy and increased global representation of women and ethnic, racially diverse employees at all levels of our business while reinforcing a culture of inclusion and belonging.

To advance environmental health, in alignment with global climate change mitigation efforts:

  • We signed the Race to Zero/Business Ambition for 1.5°C campaign, aiming to achieve net zero carbon emissions by 2045, as we further reduced our carbon footprint by 34%.

  • As part of our Healthy Lives Mission, Consumer Health signed the Ellen MacArthur Foundation’s New Plastics Economy Global Commitment, committing to reduce total annual use of virgin plastics in packaging weight by 25% by 2025.

To drive future innovation:

Our R&D spend increased to $14.7 billion, the highest annual spend in our recent history.

Our environmental goals

 

We care for the health of our planet because human health depends on it:

  • We are working to become more energy-, carbon- and water-efficient across our operations, products and supply chain.
  • We uphold strong governance and standards to ensure consistency throughout the system and product lifecycles of the Johnson & Johnson Family of Companies.
  • We are developing more sustainable products that will ultimately create a healthier planet.

How we assess our progress

We’re measuring our progress each year towards the targets outlined in our Sustainable Development Goals.

Find out more

Our annual UN Sustainable Development Goals Commitment Progress Scorecard can be found here

Find out more

 

We will be using 100% renewable electricity in Europe for Johnson & Johnson sites by 2023

Johnson & Johnson has signed two new wind and one solar virtual power purchase agreements (VPPAs) in Europe, which will provide 270,000 megawatt hours (MWh) of clean power each year (equivalent to cutting out 41,000 cars, or 82,000 homes). 30 sites across eight European countries are involved, meaning we’ll be 100% renewable in Europe by 2023.

We are a Climate A List company

In 2021, Johnson & Johnson continued to drive ambitious climate action. We made significant progress toward our Health for Humanity climate goals and increased our work with suppliers to help them measure and manage climate risks and opportunities related to their work with Johnson & Johnson. This is why J&J has again been recognised by the global environmental non-profit CDP with two of their highest accolades.

For the fourth year in a row, J&J has been placed on the prestigious CDP “A List” for leadership in Climate Action – and this is the fifth year in a row we have been recognised on CDP’s “Supplier Engagement Leaderboard.”

This recognition reflects the long-term commitment from Johnson & Johnson and from our supplier community to create more transparent dialogue, collaboration and the development of immediate actions to help us address our collective climate change risk.

J&J has a longstanding commitment to environmental health, including two decades of setting and achieving carbon reduction goals. Our current Health for Humanity climate goals are our most ambitious yet and include accelerating our transition to renewable electricity and carbon neutrality in our global operations and reducing our upstream carbon emissions.

New Deal for Europe

In 2019, Kris Sterkens, Company Group Chairman of Janssen, was one of the 380 CEOs in 24 European countries to endorse the CEO Call to Action for a New Deal for Europe: a Europe that has sustainability, climate action and inclusiveness at its core.

Find out more

Green chemistry

At Janssen, we are embracing ‘green chemistry’ principles, not only in our own laboratories but also through industry leadership. We evaluate our products’ environmental footprint, including the energy, materials and water used during the product lifecycle. We challenge our product development teams to explore new approaches, such as using renewable raw materials, reducing complexity in drug synthesis and using more environmentally friendly chemicals and processes. Most of all, we focus on designing and manufacturing the most sustainable products and health solutions to create a healthy future for us all.

Energy and emissions

Our latest climate commitments:

• By 2025, to source 100% of our electricity needs from renewable sources

• By 2030, to achieve carbon neutrality for our operations, going beyond our science-based target to reduce absolute Scope 1 and 2 emissions by 60% from 2016 levels

• By 2030, to reduce absolute upstream Scope 3 emissions by 20% from 2016 levels

We continue to advance energy efficiency and GHG emission-reduction initiatives across our global manufacturing operations and supply chain. See below for examples of how we’re achieving this.

Geothermal energy at the Janssen Beerse campus

We’re continually focusing on innovative solutions and sustainable ways of minimising our impact on the environment.

Janssen’s campus in Beerse, Belgium, uses the most energy of all Johnson & Johnson sites worldwide, with its electricity consumption currently equalling that of 38,000 homes. In 2019, we starting drilling two geothermal energy wells, each around 2.4 kilometres deep, which will bring hot water up from the ground. When completed, this renewably-sourced hot water will substantially reduce the site’s energy needs and CO2 emissions.

“We anticipate that using geothermal energy will reduce our CO2 emissions in Beerse by about 30%. This equals the emissions generated by about 3,000 households”

Marijke Anthuenis

Director, Project Management, Janssen Pharmaceutical Companies of Johnson & Johnson

The project was made possible through financial support from the European Regional Development Fund (€1.5 million), the Innovation and Enterprise Agency (€2 million) and the Flemish Energy Agency (€4 million).

LEED certification in Ireland

The Janssen Sciences Ireland campus in Cork, dedicated to biologics manufacturing and testing, achieved LEED (Leadership in Energy & Environmental Design) silver certification in 2019. LEED green building features at Cork include:

• Charging stations for up to 22 electric cars

• Covered bicycle parking

• Open space for protecting natural vegetation

• Adjustable sun shades on each building level that reduce solar glare and heat gain within the building

• Two wind turbines that provide renewable electricity for approximately 50% of the site’s annual electricity usage

Windpower in Belgium

We have also installed a windmill at our largest chemical production site in Geel, Belgium. The windmill has a capacity of 3.4 mw of electricity production and is expected to provide up to 15% of Geel’s electricity consumption.

Health for Humanity 2020 climate goals

We set ourselves the target of 30% electricity from renewable sources, and we are on track to exceed our goal of reducing Scope 1 and 2 GHG emissions by 32%. More about our work to improve environmental sustainability is found at Health for Humanity.

Changing the way we work: We Sustain

 

We Sustain is a global network of like-minded employee ambassadors, passionate about fulfilling our commitment to environmental stewardship. The idea is to help make the communities in which we live, work and play healthier places.

We Sustain local teams spread the word and inspire other employees to adopt positive sustainable behaviour. We Sustain teams set annual targets related to participation and engagement via volunteerism, awareness and educational campaigns.

“Thousands of non-recyclable marketing materials were being destroyed on a regular basis, incurring significant environmental consequences, as well as financial storage and destruction fees. Through optimising the volume of marketing materials ordered and discontinuing polluting plastic laminate – replacing it with biodegradable laminate – we will be reducing carbon emissions, saving water and limiting plastic pollution.”

Robert Saxton

Environmental Health, Safety & Sustainability Support Coordinator, Janssen EMEA

Environmental, social and governance issues

 

The topics listed below represent a broad range of environmental, social and governance issues that are important to Janssen pharmaceutical companies of Johnson & Johnson and our stakeholders.

Learn more on the Johnson and Johnson policy site or read the relevant disclosures in the annual Health for Humanity Report

• Animal Welfare

• Anti-Corruption

• Antimicrobial Resistance

• Biodiversity

• Climate Change

• Code of Business Conduct

• Community Impact

• Conflict Minerals

• Corporate Governance

• Counterfeit Healthcare Products

• Data Privacy

• Disaster Relief

• Diversity and Inclusion

• Employee Development

• Employee Health and Wellbeing

• Employment and Labor Practices

• Environmental Health and Safety

• Ethics and Compliance

• Human Rights

• Information Security

• Intellectual Property

• Materiality Assessment

• Our Credo Values

• Patient, Consumer and Product Safety

• Political Engagement and Contributions

• Pricing of Medicines

• Products in the Environment

• Quality and Compliance

• Responsible Research

• Responsible Supply Base

• Sales, Marketing and Scientific Engagement

• Stakeholder Engagement

• Sustainability Governance

• Sustainable Products and Packaging

• Sustainable Sourcing

• Tax

• Transparency

• Universal Health Coverage